Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Complementary and Integrative Medicine

Editor-in-Chief: Lui, Edmund

Ed. by Ko, Robert / Leung, Kelvin Sze-Yin / Saunders, Paul / Suntres, PH. D., Zacharias


CiteScore 2017: 1.41

SCImago Journal Rank (SJR) 2017: 0.472
Source Normalized Impact per Paper (SNIP) 2017: 0.564

Online
ISSN
1553-3840
See all formats and pricing
More options …

Evaluation of the effects of roselle (Hibiscus sabdariffa L.) on oxidative stress and serum levels of lipids, insulin and hs-CRP in adult patients with metabolic syndrome: a double-blind placebo-controlled clinical trial

Sedigheh Asgary
  • Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rasool Soltani
  • Corresponding author
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mohsen Zolghadr
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mahtab Keshvari
  • Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nizal Sarrafzadegan
  • Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2016-03-15 | DOI: https://doi.org/10.1515/jcim-2015-0030

Abstract

Background: Roselle (Hibiscus sabdariffa L.) is a plant with antihyperlipidemic and antihypertensive effects. This study aimed to evaluate the effects of roselle calyces on the serum levels of lipids and insulin, inflammation, and oxidative stress in patients with metabolic syndrome (MetS).

Methods: Forty adult patients with MetS were randomly assigned to receive either 500 mg of H. sabdariffa calyx powder or placebo once daily for 4 weeks. Systolic and diastolic blood pressures (SBP and DBP) and BMI (body mass index) as well as fasting serum levels of glucose (FPG; fasting plasma glucose), insulin, lipoproteins, triglycerides (TG), high-sensitivity C-reactive protein (hs-CRP), and malondialdehyde (MDA) were determined pre- and post-intervention and compared.

Results: H. sabdariffa significantly reduced serum TG (p=0.044) and SBP (p=0.049) compared to placebo. All other variables were not significantly affected by the interventions.

Conclusions: Daily consumption of 500 mg of H. sabdariffa L. calyx powder can decrease SBP and serum TG in MetS patients.

Keywords: clinical trial; Hibiscus sabdariffa L.; hs-CRP; lipid profile; metabolic syndrome; oxidative stress

References

  • 1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 2002;287:356–9.Google Scholar

  • 2. Ohkuma T, Fujii H, Iwase M, Ogata-Kaizu S, Ide H, Kikuchi Y, et al. U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: The Fukuoka Diabetes Registry. Metab Clin Exp 2014;63:484–91.Google Scholar

  • 3. Kendall DM, Harmel AP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care 2002;8:S635–53.Google Scholar

  • 4. Lorenzo C, Okoloise M, Williams K, Stern M, Haffner S. The metabolic syndrome as predictor of type 2 diabetes. The San Antonio Heart Study. Diab Care 2003;26:3153–9.Google Scholar

  • 5. Martins D, Tareen N, Ogedegbe G, Pan D, Norris K. The relative risk of cardiovascular death among racial and ethnic minorities with metabolic syndrome: data from the NHANES-II mortality follow-up. J Natl Med Assoc 2008;100:565–71.Google Scholar

  • 6. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001;50:2384–9.Google Scholar

  • 7. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and update meta-analyses. BMJ 2000;321:199–204.Google Scholar

  • 8. Belfki H, Ben Ali S, Bougatef S, Ben Ahmed D, Haddad N, Jmal A, et al. Relationship of C-reactive protein with components of the metabolic syndrome in a Tunisian population. Eur J Intern Med 2012;23:e5–9.Google Scholar

  • 9. Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diab Res Clin Pract 2006;71:92–100.Google Scholar

  • 10. Nakamura H, Ito H, Egami Y, Kaji Y, Maruyama T, Koike G, et al. Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome. Diab Res Clin Pract 2008;79:330–6.Google Scholar

  • 11. Mahadik SR, Deo SS, Mehtalia DS. Relation of C-reactive protein with the components of metabolic syndrome in Asian subjects. Diab Metab Syndr 2008;2:29–35.Google Scholar

  • 12. Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: The oxidative stress. Nutr Metab Cardiovasc Dis 2010;20:72–7.Google Scholar

  • 13. Caimi G, Hopps E, Montana M, Noto D, Canino B, Lo Presti R, et al. Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome. Diab Metab Syndr 2012;6:132–5.Google Scholar

  • 14. Demircan N, Gurel A, Armuctu F, Unalacak M, Aktunc E, Atmaca H. The evaluation of serum cystatin C, malonildialdehyde and total antioxidant status in patients with metabolic syndrome. Med Sci Monit 2008;14:97–101.Google Scholar

  • 15. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations. Diabetes 2003;52:2346–52.Google Scholar

  • 16. Aziz Z, Wong SY, Chong NJ. Effects of Hibiscus sabdariffa L. on serum lipids: a systematic review and meta-analysis. J Ethnopharmacol 2013;150:442–50.Web of ScienceGoogle Scholar

  • 17. Ali BH, Wabel NA, Blunden G. Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: a review. Phytother Res 2005;19:369–75.Google Scholar

  • 18. Jonadet M, Bastide J, Bastide P, Boyer B, Carnat A, Lamaison J. In vitro enzyme inhibitory and in vivo cardioprotective activities of Hibiscus sabdariffa L. J Pharm Belg 1990;45:120–4.Google Scholar

  • 19. Chen C-C, Chou F-P, Ho Y-C, Lin W-L, Wang C-P, Kao E-S, et al. Inhibitory effects of Hibiscus sabdariffa L extract on low-density lipoprotein oxidation and anti-hyperlipidemia in fructose-fed and cholesterol-fed rats. J Sci Food Agric 2004;84:1989–96.Google Scholar

  • 20. Abu-Irmaileh BE, Afifi FU. Herbal medicine in Jordan with special emphasis on commonly used herbs. J Ethnopharmacol 2003;89:193–7.Google Scholar

  • 21. Dafallah AA, Al-Mustafa Z. Investigation of the anti-inflammatory activity of Acacia nilotica and Hibiscus sabdariffa. Am J Chin Med 1996;24:263–9.Google Scholar

  • 22. Hasanloo T, Sepehrifar R, Hajimehdipoor H. Levels of phenolic compounds and their effects on antioxidant capacity of wild Vaccinium arctostaphylos L. (Qare-Qat) collected from different regions of Iran. Turk J Biol 2011;35:371–7.Web of ScienceGoogle Scholar

  • 23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486–97.Google Scholar

  • 24. Gurrola-Díaz CM, García-López PM, Sánchez-Enríquez S, Troyo-Sanromán R, Andrade-González I, Gómez-Leyva JF. Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy). Phytomedicine 2010;17:500–5.Web of ScienceGoogle Scholar

  • 25. Ochani PC, D’Mello P. Antioxidant and antihyperlipidemic activity of Hibiscus sabdariffa Linn. leaves and calyces extracts in rats. J Exp Biol 2009;47:276–82.Google Scholar

  • 26. Hirunpanich V, Utaipat A, Morales NP, Bunyapraphatsara N, Sato H, Herunsale A, et al. Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats. J Ethnopharmacol 2006;103:252–60.Google Scholar

  • 27. Mozaffari-Khosravi H, Jalali-Khanabadi BA, Afkhami-Ardekani M, Fatehi F. Effects of sour tea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes. J Altern Complement Med 2009;15:899–903.Google Scholar

  • 28. Kuriyan R, Kumar D, R R, Kurpad AV. An evaluation of the hypolipidemic effect of an extract of Hibiscus sabdariffa leaves in hyperlipidemic Indians: a double blind, placebo controlled trial. BMC Complement Altern Med 2010;10:27.Web of ScienceGoogle Scholar

  • 29. Olatunji LA, Adebayo JO, Oguntoye OB, Olatunde NO, Olatunji VA, Soladoye AO. Effects of aqueous extracts of petals of red and green Hibiscus sabdariffa on plasma lipid and hematological variables in rats. Pharm Biol 2005;43:471–4.Google Scholar

  • 30. Farombi EO, Ige OO. Hypolipidemic and antioxidant effects of ethanolic extract from dried calyx of Hibiscus sabdariffa in alloxan-induced diabetic rats. Fundam Clin Pharmacol 2007;21:601–9.Web of ScienceGoogle Scholar

  • 31. Mohagheghi A, Maghsoud S, Khashayar P, Ghazi-Khansari M. The effect of Hibiscus sabdariffa on lipid profile, creatinine, and serum electrolytes: a randomized clinical trial. ISRN Gastroenterol 2011;2011:4.Google Scholar

  • 32. Chang HC, Peng CH, Yeh DM, Kao ES, Wang CJ. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food Funct 2014;5:734–9.Web of ScienceGoogle Scholar

  • 33. Mojiminiyi FB, Dikko M, Muhammad BY, Ojobor PD, Ajagbonna OP, Okolo RU, et al. Antihypertensive effect of an aqueous extract of the calyx of Hibiscus sabdariffa. Fitoterapia 2007;78:292–7.Web of ScienceGoogle Scholar

  • 34. McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr 2010;140:298–303.Web of ScienceGoogle Scholar

  • 35. Mozaffari-Khosravi H, Jalali-Khanabadi BA, Afkhami-Ardekani M, Fatehi F, Noori-Shadkam M. The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. J Hum Hypertens 2009;23:48–54.Google Scholar

  • 36. Herrera-Arellano A, Flores-Romero S, Chávez-Soto MA, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine 2004;11:375–82.Google Scholar

  • 37. Joven J, March I, Espinel E, Fernández-Arroyo S, Rodríguez-Gallego E, Aragonès G, et al. Hibiscus sabdariffa extract lowers blood pressure and improves endothelial function. Mol Nutr Food Res 2014;58:1374–8.Google Scholar

About the article

Received: 2015-05-12

Accepted: 2016-01-20

Published Online: 2016-03-15

Published in Print: 2016-06-01


Citation Information: Journal of Complementary and Integrative Medicine, Volume 13, Issue 2, Pages 175–180, ISSN (Online) 1553-3840, ISSN (Print) 2194-6329, DOI: https://doi.org/10.1515/jcim-2015-0030.

Export Citation

©2016 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Priscila Silva Figueiredo, Aline Inada, Melina Ribeiro Fernandes, Daniela Granja Arakaki, Karine Freitas, Rita Avellaneda Guimarães, Valter Aragão do Nascimento, and Priscila Aiko Hiane
Molecules, 2018, Volume 23, Number 4, Page 877
[3]
Shun-Ting Chou, Hsin-Yi Lo, Chia-Cheng Li, Lu-Chen Cheng, Pei-Chi Chou, Yu-Chen Lee, Tin-Yun Ho, and Chien-Yun Hsiang
Journal of Ethnopharmacology, 2016, Volume 194, Page 617

Comments (0)

Please log in or register to comment.
Log in